|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0144576,
umls-concept:C0205420,
umls-concept:C0205462,
umls-concept:C0281361,
umls-concept:C0445204,
umls-concept:C0600688,
umls-concept:C0851346,
umls-concept:C0871261,
umls-concept:C1274040,
umls-concept:C1514888,
umls-concept:C1521828,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2002-5-15
|
|
pubmed:abstractText |
To evaluate the toxicity of a preoperative regimen of paclitaxel and concurrent external-beam radiation therapy, pancreaticoduodenectomy, and electron-beam intraoperative radiation therapy (EB-IORT) for patients with resectable pancreatic adenocarcinoma.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AbbruzzeseJames LJL,
pubmed-author:CharnsangavejChusilpC,
pubmed-author:ClearyKaren RKR,
pubmed-author:CraneChristopher NCN,
pubmed-author:EvansDouglas BDB,
pubmed-author:JanjanNora ANA,
pubmed-author:LeeJeffrey EJE,
pubmed-author:LenziRenatoR,
pubmed-author:PistersPeter W TPW,
pubmed-author:VautheyJ NicolasJN,
pubmed-author:WolffRobert ARA
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2537-44
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:12011133-Adenocarcinoma,
pubmed-meshheading:12011133-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:12011133-Combined Modality Therapy,
pubmed-meshheading:12011133-Disease-Free Survival,
pubmed-meshheading:12011133-Dose Fractionation,
pubmed-meshheading:12011133-Follow-Up Studies,
pubmed-meshheading:12011133-Humans,
pubmed-meshheading:12011133-Neoplasm Staging,
pubmed-meshheading:12011133-Paclitaxel,
pubmed-meshheading:12011133-Pancreatectomy,
pubmed-meshheading:12011133-Pancreatic Neoplasms,
pubmed-meshheading:12011133-Pilot Projects,
pubmed-meshheading:12011133-Survival Rate,
pubmed-meshheading:12011133-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome.
|
|
pubmed:affiliation |
Pancreatic Tumor Study Group, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. ppisters@mdanderson.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
